Across industries, the market is accelerating. Yet it’s a nuanced environment, in which quality is king, strategic options are expanding, technology is transforming the landscape, and change is a constant. Overall, 2026 offers a wealth of potential for buyers and sellers who can navigate this complexity with strategic conviction and tactical creativity. Here, Harris Williams explores how these dynamics are driving M&A opportunities in healthcare and life sciences.
Read the full article: Harris Williams Outlook 2026: Healthcare & Life Sciences //
Source: https://assets.ctfassets.net/xpbu77rkft4z/31mjoEAd4pkBlOlzza6O0R/fab7882b33b3e474ed1e2c8f4ad54a2c/FIRM_HCLS_Outlook_2026_PDF_FINAL.pdf